1 / 46

Lecture 8

Lecture 8. Oncogene and anti-oncogene. Zhihong Li （李志红）. Normal cells. Benign. Malignant cancer. Cancer cells vs. normal cells: what's different?. Cells normally grow, reproduce and die in response to signals inside and outside the body in an orderly way.

oneida
Download Presentation

Lecture 8

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Lecture 8 Oncogene and anti-oncogene Zhihong Li（李志红）

  2. Normal cells Benign Malignant cancer Cancer cells vs. normal cells: what's different? • Cells normally grow, reproduce and die in response to signals inside and outside the body in an orderly way. • Malignant tissues can invade and damage other tissues and organs. Cancer cells can then break away from the tumour and enter the bloodstream or lymphatic system, spreading the cancer to other parts of the body. (metastasis)

  3. Cancer Cell Do Not Grow Faster Than Normal Cells Rather, Their Growth is Just Uncontrolled

  4. Death Proliferation Differentiation Cancer: disruption of cellular equilibrium Death Proliferation Differentiation

  5. Causes of Cancer Heredity

  6. Cancer- multi-step and multi-gene disease All types of cancers are caused bychanges in genes. Cancer -a genetic diseaseof somatic cells. Cancer - the most common human genetic disease. Not every gene is involved in carcinogenesis! Predominant mechanisms for cancers are: impairment of a DNA repair pathway transformation of normal genes into oncogenes  malfunction of anti-oncogenes(tumor suppressor genes)

  7. Relationship of oncogene, anti-oncogene and growth factor

  8. Cellular controldepends on a constant balance proto-oncogenes- favour cell reproduction, anti-oncogenes- prevent cell reproduction. Imbalance:proto-oncogenesover-expressed, anti-oncogenesinactivated or lost.

  9. §1 Oncogene

  10. oncogene: • These genes code for proteins that are capable of stimulating cell growth and division. • In normal tissues and organisms, such growth-stimulating proteins are regulated, so that growth is appropriately limited. • However, changes/mutation in these genes may result in loss of growth regulation, leading to uncontrolled cell proliferation and tumor development. • Dominant mutation:one copy is sufficient to cause cancer. (different than tumor-suppressors, recessive mutation)

  11. Oncogene • found in viruses or as part of the normal genome. • v-onc: virus oncogene • c-onc: cellular-oncogene or proto-oncogene

  12. Virus- oncogene (v-onc) • Genes are in viruses that can cause tumors in vivo and transform the cell in vitro. • First link between viruses and cancer proposed by Francis Peyton Rous in 1910: • cell-free extracts from chicken tumors injected into healthy chickens caused new tumors.

  13. In 1910, Peyton Rous found the first retrovirus (Rous Sarcoma Virus, RSV) in a chickens filtrated sarcoma. • Rous got the Nobel Prize in Physiology and Medicine in 1966.

  14. Structure of RSV genome 9392 bp wide type viral genes oncogene pol env gag src LTR LTR to initiate and regulate transcription tyrosine kinase 526 residue 60 kD

  15. Cellular Oncogene (c-onc) • Or proto-oncogene • code for proteins that help to regulate cell growth and differentiation. • Genes are in static or low-level expression state in normal cells under the normal situation. • The proto-oncogene can become an oncogenedue to mutations or increased expression.

  16. Product and Function of Proto-oncogene • Extracellular growth factors • Transmembrane growth factor receptors • Intracellular signal transduction proteins • Intranuclear transcription factors

  17. Category and major product of c-oncogene 1. src family — tyrosine protein kinase 2. ras familiy — P21（GTPase activity） 3. myc familiy — intranuclear DNA binding protein 4. sis familiy — P28 (similar platelet derived growth factor) 5. myb familiy — intranuclear transcription factor

  18. Mechanisms of Oncogene Activation • Obtaining a strong promoter or enhancer • Group translocation or chromosome rearrangements • Proto-oncogene amplification • Gene mutation

  19. avian leukemia virus genome ssRNA host cell genome c-myc LTR dsDNA to increase c-myc gene expression, 30-100 times, compare with no infection. 1) Obtaining a strong promoter or enhancer

  20. c-Myc • Myc (c-Myc) codes for a protein that binds to the DNA of other genes and is therefore a transcription factor. • Myc protein regulate expression of 15% of all genes through binding on Enhancer Box sequences (E-boxes).

  21. 2) Gene translocation • Chronic myelogenous leukemia (CML) is a cancer of the blood system in which too many white blood cells (WBCs) are made in the bone marrow. • What causes CML? • In almost everyone with CML, the genetic material (chromosomes) in the leukemia cells has an abnormal feature called thePhiladelphia(Ph) chromosome.

  22. produces a new, abnormal gene called bcr-abl. This abnormal gene produces Bcr-Abl tyrosine kinase, an abnormal protein that causes the excess WBCs typical of CML.

  23. ras or c-myc amplification expression of ras or c-myc is increased obviously 3) Proto-oncogene amplification

  24. 4) Point mutation Ras Proto-oncogene • Mutated in 30% of all cancers. • A “molecular switch” in the signal transduction pathway leading from growth factors to gene expression controlling cell proliferation: • GF  receptor   Ras    TF  target genes  growth. • A single amino acid change in Ras protein can cause constant stimulation of the pathway, even in the absence of growth factors.

  25. In cancer cells, the RAS gene product is locked into its GTP-binding shape and does not require a signal at the receptor in order to stimulate cell division Ras Proto-Oncogene In response to growth factor binding at receptor, the Ras gene product combines with GTP to promote cell division

  26. DNA Protein Gly GGC normal Val GTC carcinoma H-ras

  27. Genetic Disease Associated with Ras • The altered H-Ras protein is permanently activated within the cell. • This overactive protein directs the cell to grow and divide in the absence of outside signals, leading to uncontrolled cell division and the formation of a tumor---Bladder cancer. • Ras family: H-Ras, K-Ras, R-Ras and N-Ras • The presence of ras mutations is detected in several human tumors- 90% of pancreatic, 50% of colon and 30% of lung.

  28. §2 Anti-oncogene

  29. Tumor suppressor gene (anti-oncogene) • A gene whose protein products inhibit cell division, thereby preventing uncontrolled cell growth.

  30. Tumour suppressor genes Act as a brake for cell division “Guardian of the genome” PROBLEM: Mutation in tumour suppressor genes = brakes don’t work, or there is an accumulations of mutations (DNA repair enzymes)

  31. Functions of tumour suppressor genes • Coding the restrained protein relating to cell cycle control. • When tumor suppressive gene is deleted and mutated, there is an induced occurrence of tumors. • Rb gene and P53 gene.

  32. Retinoblastoma (Rb gene) • Diagnosis: “Cat’s eye” reflection in affected eye. • Most common cancer of infants and children (1/20,000 U.S. live births). • Survival > 90% with early diagnosis and treatment. • Individuals at greater risk of developing other cancers.

  33. People prone to retinoblastoma have one mutated copy of the Rb gene (Rb-) and one normal copy (Rb+). • Conversion of the Rb+ copy to Rb- by mutation leads to uncontrolled growth of retinal cells. Recessive mutation

  34. Knudson’s “Two-Hit” Model for Retinoblastoma Normal 2 intact copies Predisposed 1 intact copy 1 mutation Affected Loss of both copies Modified from Time, Oct. 27, 1986

  35. Mechanism of action of Rb gene E2F = transcription factor Rb = product of Retinoblastoma gene, inhibits action of E2F until chemically modified

  36. P53 gene • P53 gene encodes the protein which molecular weight is 53kD. • The “Last Gatekeeper” gene since malignant state not attained despite the presence of other cancer-causing mutations until p53 is inactivated by mutation.

  37. Biologic function of P53 protein • Suppressing cell cycle • Suppressing transformation function of some oncogenes • Monitoring cell DNA damage • Inducing the cell apoptosis

  38. Function of Tumor Suppressor Gene p53 • p53 initiates repair of damaged DNA • if DNA cannot be repaired, it initiates apoptosis

  39. Cancer is a multistep process

  40. Environmental factors (physical and chemical) Oncogenic viruses Mutations Oncogene activation Inactive antioncogenes Diminished regulation by apoptosis genes Carcinogenesis A simplified hypothesis for the development of cancer

  41. Points • Oncogene • v-onc • c-onc (proto-oncogene) • Product and Function of Proto-oncogene • Mechanisms of Oncogene Activation • Obtaining a stronge promoter or enhancer • Group translocation or chromosome rearrangements • Proto-oncogene amplification • Gene mutation • Tumor suppressor gene (anti-oncogene) • Rb gene and P53 gene

More Related